Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Proof-of-Concept for a Novel Optical Aperture Contact Lens in Presbyopia and Keratoconus

NCT: NCT07559188 · NOT_YET_RECRUITING

NCT IDNCT07559188
StatusNOT_YET_RECRUITING
Start Date2026-05-01
Completion2026-06-30

Brief Summary

The purpose of this clinical study is to evaluate the effectiveness of the NOA lens, a custom-made scleral contact lens developed by Azalea Vision BV, in improving visual quality for individuals with keratoconus and presbyopia. This clinical study investigates a new lens design featuring a specific central aperture (opening) intended to enhance image quality by increasing depth of focus and reducing optical aberrations. The NOA lens serves as a functional prototype for future "smart lens" technology, specifically the ALMA Smart Lens. The study aims to determine if this specialized lens provides a solution for patients whose visual needs are not fully met by conventional glasses or contact lenses. The investigation will compare a standard refractive scleral lens (Type 1) against the aperture-integrated lens (Type 2) to validate the "pinhole effect" in improving vision and reducing higher-order aberrations.

Frequently Asked Questions

What is Proof-of-Concept for a Novel Optical Aperture Contact Lens in Presbyopia and Keratoconus?

Proof-of-Concept for a Novel Optical Aperture Contact Lens in Presbyopia and Keratoconus is a clinical trial registered under NCT07559188. Current status: NOT_YET_RECRUITING.

What is the status of NCT07559188?

The current status of NCT07559188 (Proof-of-Concept for a Novel Optical Aperture Contact Lens in Presbyopia and Keratoconus) is: NOT_YET_RECRUITING.

When did Proof-of-Concept for a Novel Optical Aperture Contact Lens in Presbyopia and Keratoconus start?

Proof-of-Concept for a Novel Optical Aperture Contact Lens in Presbyopia and Keratoconus started on 2026-05-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.